[
    [
        {
            "time": "2023-04-15",
            "original_text": "国盛证券维持康龙化成买入评级：一季报业绩超预期，盈利能力持续提升",
            "features": {
                "keywords": [
                    "康龙化成",
                    "买入评级",
                    "一季报",
                    "业绩超预期",
                    "盈利能力提升"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国盛证券维持康龙化成买入评级：一季报业绩超预期，盈利能力持续提升",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-04-16",
            "original_text": "【权益变动】康龙化成(03759.HK)获摩根大通增持29.1518万股",
            "features": {
                "keywords": [
                    "康龙化成",
                    "摩根大通",
                    "增持",
                    "权益变动"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【权益变动】康龙化成(03759.HK)获摩根大通增持29.1518万股",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-04-17",
            "original_text": "康龙化成现5笔大宗交易 共成交15,460.30万元",
            "features": {
                "keywords": [
                    "康龙化成",
                    "大宗交易",
                    "成交额"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康龙化成现5笔大宗交易 共成交15,460.30万元",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 3,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-04-18",
            "original_text": "渤海证券给予康龙化成增持评级，季报点评：业绩稳健增长，临床研究服务比重持续提升",
            "features": {
                "keywords": [
                    "康龙化成",
                    "渤海证券",
                    "增持评级",
                    "季报",
                    "临床研究服务"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "渤海证券给予康龙化成增持评级，季报点评：业绩稳健增长，临床研究服务比重持续提升",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-04-19",
            "original_text": "葛兰豪掷10亿加仓！这家CXO交出超预期业绩，要跟老大药明抢位置？",
            "features": {
                "keywords": [
                    "康龙化成",
                    "葛兰",
                    "加仓",
                    "超预期业绩",
                    "CXO"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "葛兰豪掷10亿加仓！这家CXO交出超预期业绩，要跟老大药明抢位置？",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-04-20",
            "original_text": "JPMorgan Chase & Co.增持康龙化成股份约29.15万股",
            "features": {
                "keywords": [
                    "康龙化成",
                    "JPMorgan Chase",
                    "增持"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "JPMorgan Chase & Co.增持康龙化成股份约29.15万股",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-04-21",
            "original_text": "康龙化成(300759)：业绩稳健增长 临床研究服务比重持续提升",
            "features": {
                "keywords": [
                    "康龙化成",
                    "业绩稳健增长",
                    "临床研究服务"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康龙化成(300759)：业绩稳健增长 临床研究服务比重持续提升",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-04-22",
            "original_text": "【康龙化成|一季度点评】业绩继续快速增长，盈利能力不断提升【安信医药马帅团队】",
            "features": {
                "keywords": [
                    "康龙化成",
                    "一季度点评",
                    "业绩快速增长",
                    "盈利能力提升"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【康龙化成|一季度点评】业绩继续快速增长，盈利能力不断提升【安信医药马帅团队】",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-04-23",
            "original_text": "【浙商|孙建】康龙化成：略超预期，看好盈利能力持续提升趋势",
            "features": {
                "keywords": [
                    "康龙化成",
                    "略超预期",
                    "盈利能力提升"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【浙商|孙建】康龙化成：略超预期，看好盈利能力持续提升趋势",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-04-24",
            "original_text": "康龙化成(03759.HK)首季盈利增1.4倍",
            "features": {
                "keywords": [
                    "康龙化成",
                    "首季盈利",
                    "增长1.4倍"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康龙化成(03759.HK)首季盈利增1.4倍",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-04-25",
            "original_text": "港股盘前必读：港交所承认正研究SPAC上市机制 最快在6月底前咨询市场",
            "features": {
                "keywords": [
                    "港股",
                    "港交所",
                    "SPAC",
                    "上市机制"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "港股盘前必读：港交所承认正研究SPAC上市机制 最快在6月底前咨询市场",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]